FWA
IDXX icon

FSC Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

FSC Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6
Closed -$2K – 191
2022
Q3 		$2K Hold
6
– – 0.02% 182
2022
Q2 		$2K Buy
+6
New +$2.45K 0.02% 181

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FSC Wealth Advisors's IDXX Position: Q4 2022 in Review

FSC Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 6 shares — an estimated $2K sold.

FSC Wealth Advisors first reported a position in IDXX in Q2 2022 and held it in 2 quarters. The position peaked at $2K in Q3 2022. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • FSC Wealth Advisors reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
  • FSC Wealth Advisors sold 6 Idexx Laboratories shares in Q4 2022, an estimated $2K.
  • FSC Wealth Advisors first reported a position in Idexx Laboratories in Q2 2022 and held it in 2 quarters.
  • FSC Wealth Advisors's Idexx Laboratories position peaked at $2K in Q3 2022.
  • 999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on FSC Wealth Advisors's 13F filing for Q4 2022, filed 17 Jan 2023.